AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
3 Min Read

3 answers to know about Sunshine Act data going public

The second release of physicians’ financial data under the Physician Payments Sunshine Act, also known as the Open Payments program, was June 30. Learn the answers to three questions patients or others may ask you about your 2014 financial data.

Medicare & Medicaid
·
1 Min Read

Physicians move to lower generic prescription drug costs

Physicians at the 2015 AMA Annual Meeting voted to take action to address generic prescription drug increases. The AMA Council on Medical Service is expected to release a report at the 2015 AMA Interim Meeting in November that examines both brand name and generic price increases.

Behavioral Health
·
2 Min Read

Review financial data before it goes public in June

Physicians have 45 days to review and dispute reports regarding their financial interactions with manufacturers of drugs and medical devices reported under the Physician Payments Sunshine Act. Here’s what you need to know about the process before data is made available to the public in June.

Medicare & Medicaid
·
2 Min Read

CME cleared from reporting under Sunshine Act

With the release of the 2015 Medicare Physician Fee Schedule final rule Oct. 31, the Centers for Medicare & Medicaid Services (CMS) made it official: funding for independent continuing medical education (CME) will not be subject to reporting under the Physician Payments Sunshine Act as initially proposed by the agency earlier this summer.

Medicare & Medicaid
·
3 Min Read

How AMA has advocated for Sunshine Act implementation overhaul

As the Centers for Medicare & Medicaid Services (CMS) rolls out the online database of physicians’ financial interactions with manufacturers of drugs and medical devices, troubling questions remain about the accuracy of the data and the lack of context with which it is being presented.

Medicare & Medicaid
·
4 Min Read

6 things you need to know about hydrocodone reclassification

The Drug Enforcement Administration reclassified hydrocodone combination products as Schedule II controlled substances. You need to know these 6 six key points about major changes to prescribing practices.

Behavioral Health
·
3 Min Read

Time running out to review Sunshine data—and it isn't very accurate

Less than two weeks remain for physicians to review and dispute data about their financial interactions with medical device and drug manufacturers before the information goes public Sept. 30.

Medicare & Medicaid
·
2 Min Read

Troubles with Sunshine Act website? We're taking them to CMS

As the federal website through which physicians can review their Sunshine Act financial data continues to experience technical problems, you can share your experience using the site in a brief survey, open through Monday.

Medicare & Medicaid
·
3 Min Read

Physicians ask CMS to postpone Sunshine Act data release

The Physician Payments Sunshine Act roll-out is suffering from a major lack of communication, a shortened timeline and a confusing registration process, the AMA and 112 specialty and state medical societies told the Centers for Medicare & Medicaid Services in a letter.

Medicare & Medicaid